Product Information

TASIMELTEON 20 MG CAPSULE is a generic product labeled by Apotex Corp., priced at $211.7170 per EA under NDC 60505466503. Its NADAC has been published 114 times since Sep 18, 2024.

FDA first approved this application on Dec 20, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TASIMELTEON 20 MG CAPSULE

Tasimelteon
$211.7170per EA

Strength

20 mg/1

Manufacturer

Apotex Corp.

NDC

60505466503

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TASIMELTEON

Approval Type

Generic (ANDA)

FDA Application

ANDA211607

FDA Approved

12/20/2022

TE Code

AB

On Market Since

1/5/2024

Pharmacological Classes

Melatonin Receptor Agonist
Melatonin Receptor Agonists

Price Statistics

The NADAC for TASIMELTEON 20 MG CAPSULE has been published 114 times since Sep 18, 2024, and over the history we have for it it has declined 65.2%. The table below summarizes its recorded NADAC range and movement.

Current price$211.7170 per EA
All-time high$608.5590 (Sep 10, 2025)
All-time low$211.7170 (Nov 18, 2026)
52-week high$405.5994
52-week low$211.7170
Median price$412.3052
Average price$468.2726
Largest weekly change-31.1% (Sep 17, 2025)
Weeks tracked114
Tracking sinceSep 18, 2024

Price History

1W

-0.9%

1M

-7.2%

3M

-21.9%

6M

-40.8%

1Y

-47.7%

3Y

N/A

5Y

N/A

All

-65.2%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TASIMELTEON 20 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TASIMELTEON 20 MG CAPSULE, manufactured by Apotex Corp., is $211.7170 per EA (NDC 60505466503), effective Nov 18, 2026.

How has the price of TASIMELTEON 20 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TASIMELTEON 20 MG CAPSULE has declined 65.2%. It has been tracked across 114 weekly CMS publications since Sep 18, 2024.

What are the highest and lowest recorded NADAC prices for TASIMELTEON 20 MG CAPSULE?

Since Sep 18, 2024, the NADAC for TASIMELTEON 20 MG CAPSULE has ranged from a low of $211.7170 (Nov 18, 2026) to a high of $608.5590 (Sep 10, 2025), with a median of $412.3052 per EA.

Are there cheaper alternatives to TASIMELTEON 20 MG CAPSULE?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TASIMELTEON 20 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TASIMELTEON 20 MG CAPSULE?

TASIMELTEON 20 MG CAPSULE (NDC 60505466503) is labeled by Apotex Corp., and CMS classifies it as a generic product.